Anna Ringheim
YOU?
Author Swipe
View article: Quantification of the pharmacokinetics of 68Ga-PSMA-11 in prostate cancer patients using hybrid positron emission tomography and magnetic resonance imaging
Quantification of the pharmacokinetics of 68Ga-PSMA-11 in prostate cancer patients using hybrid positron emission tomography and magnetic resonance imaging Open
Introduction: Positron emission tomography with the radiopharmaceutical Glu-NH-CO-NH-Lys(Ahx)-HBED-CC labeled with Ga ( Ga-PSMA-11), targeting the prostatespecific membrane antigen, has demonstrated great potential for detection and stagin…
View article: Pharmacokinetic modeling of [68Ga]PSMA-11 in primary prostate cancer patients
Pharmacokinetic modeling of [68Ga]PSMA-11 in primary prostate cancer patients Open
15 patients underwent a 60-minute dynamic [68Ga]PSMA-11 PET scan (patient 101P had its scan interrupted at 40 min) in list-mode with the field of view over the pelvic area. PET data were reconstructed with a 3D-Ordered-Subsets Expectation …
View article: Pharmacokinetic modeling of 68Ga-PSMA-11 in primary prostate cancer patients
Pharmacokinetic modeling of 68Ga-PSMA-11 in primary prostate cancer patients Open
15 patients underwent a 60-minute dynamic 68Ga-PSMA-11 PET scan (patient 101P had its scan interrupted at 40 min) in list-mode with the field of view over the pelvic area. PET data were reconstructed with a 3D-Ordered-Subsets Expectation M…